• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用胸苷激酶1自身抗体、胸苷激酶抗原、细胞外蛋白激酶A自身抗体和C反应蛋白早期检测犬类恶性肿瘤。

Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs.

作者信息

Kim Yoonhee, Lee Wonhee, Kim Byunggak, Jang Bonghwan, Yu Kyung-Rok, Kim Hong Sook, Ryu Minok, Oh Yein, Seo Kyoungwon, Park Chul, Choi Ulsoo, Bhang Dongha, Youn Hwayoung

机构信息

Department of Veterinary Clinical Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea.

Biattic Inc., #306, 16, Heungan-daero 427beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea.

出版信息

J Vet Intern Med. 2025 Jan-Feb;39(1):e17266. doi: 10.1111/jvim.17266.

DOI:10.1111/jvim.17266
PMID:39639774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11627517/
Abstract

BACKGROUND

Although the importance of early diagnosis of malignant tumors is a major concern, an easily accessible in-house method has not been established.

OBJECTIVES

To investigate the most optimal model by combining thymidine kinase 1 (TK1) autoantibody, extracellular protein kinase A (ECPKA) autoantibody, TK1 antigen, C-reactive protein (CRP), age, breed, and sex.

ANIMALS

Serum samples from 1702 dogs were collected from local animal hospitals and referral animal medical centers in Korea.

METHODS

TK1 autoantibody, ECPKA autoantibody, and CRP were measured using LFIA methods in serum samples of dog to design a new neoplastic index (NI) for early detection of malignant tumors in dogs.

RESULTS

AUC of TK1 autoantibody model with TK1 antigen, CRP, age, and breed in multiple logistic regression analysis was 0.966 (TK1 autoantibody, P = .0005; TK1 antigen, P = .0003), and when the cutoff value was 0.417, the specificity was 87.1%, and sensitivity was 96.4%. Regression coefficients were 24.4, 20.5, 24.8, 10.6, respectively in TK1 autoantibody, TK1 antigen, CRP, and age, and the effect by breed (regression coefficient 2.1, 3.0) was the lowest. The same multiple logistic regression analysis on dogs with lymphoma, and AUC of TK1 autoantibody model was 0.981 (all P < .0001, TK1 antigen P = .09), when the cutoff value was 0.352, the specificity was 92.9%, and sensitivity was 93.7%.

CONCLUSIONS AND CLINICAL IMPORTANCE

The NI including TK1 autoantibody could be useful in the screening test for both lymphoma and other tumors.

摘要

背景

尽管恶性肿瘤的早期诊断至关重要,但尚未建立一种易于获取的内部检测方法。

目的

通过结合胸苷激酶1(TK1)自身抗体、细胞外蛋白激酶A(ECPKA)自身抗体、TK1抗原、C反应蛋白(CRP)、年龄、品种和性别,研究最优化模型。

动物

从韩国当地动物医院和转诊动物医疗中心收集了1702只犬的血清样本。

方法

采用LFIA法检测犬血清样本中的TK1自身抗体、ECPKA自身抗体和CRP,以设计一种用于早期检测犬恶性肿瘤的新肿瘤指数(NI)。

结果

在多因素逻辑回归分析中,包含TK1自身抗体、TK1抗原、CRP、年龄和品种的模型的AUC为0.966(TK1自身抗体,P = 0.0005;TK1抗原,P =  0.0003),当临界值为0.417时,特异性为87.1%,敏感性为96.4%。TK1自身抗体、TK1抗原、CRP和年龄的回归系数分别为24.4、20.5、24.8、10.6,品种的影响(回归系数2.1、3.0)最小。对淋巴瘤犬进行相同的多因素逻辑回归分析,TK1自身抗体模型的AUC为0.981(所有P < 0.0001,TK1抗原P = 0.09),当临界值为0.352时,特异性为92.9%,敏感性为93.7%。

结论及临床意义

包含TK1自身抗体的NI可用于淋巴瘤和其他肿瘤的筛查试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/bdf2c0091cdf/JVIM-39-e17266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/b70e83f0772a/JVIM-39-e17266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/63583d01a41d/JVIM-39-e17266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/917661e6164c/JVIM-39-e17266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/bdf2c0091cdf/JVIM-39-e17266-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/b70e83f0772a/JVIM-39-e17266-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/63583d01a41d/JVIM-39-e17266-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/917661e6164c/JVIM-39-e17266-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f2d/11627517/bdf2c0091cdf/JVIM-39-e17266-g002.jpg

相似文献

1
Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs.使用胸苷激酶1自身抗体、胸苷激酶抗原、细胞外蛋白激酶A自身抗体和C反应蛋白早期检测犬类恶性肿瘤。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17266. doi: 10.1111/jvim.17266.
2
Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.血清胸苷激酶 1 蛋白浓度及其自身抗体的存在可作为筛查恶性肿瘤犬的生物标志物。
J Vet Intern Med. 2024 Jan-Feb;38(1):300-307. doi: 10.1111/jvim.16946. Epub 2023 Dec 13.
3
Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.细胞外环磷酸腺苷依赖性蛋白激酶A自身抗体和C反应蛋白作为犬癌症诊断的血清生物标志物。
Vet Comp Oncol. 2019 Mar;17(1):99-106. doi: 10.1111/vco.12450. Epub 2018 Nov 28.
4
Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.自发性患癌犬的1型胸苷激酶和C反应蛋白浓度
J Vet Intern Med. 2016 Jul;30(4):1159-66. doi: 10.1111/jvim.13954. Epub 2016 May 23.
5
A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.一种用于定量不同恶性肿瘤犬血清中胸苷激酶1蛋白水平的新型夹心酶联免疫吸附测定法有助于疾病管理。
PLoS One. 2015 Sep 14;10(9):e0137871. doi: 10.1371/journal.pone.0137871. eCollection 2015.
6
Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.血清胸苷激酶1和C反应蛋白作为筛查临床健康犬隐匿性疾病生物标志物的研究
Vet Comp Oncol. 2015 Dec;13(4):373-84. doi: 10.1111/vco.12052. Epub 2013 Jul 16.
7
Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.免疫介导性溶血性贫血、血小板减少症和多关节病犬的血清胸苷激酶1、犬C反应蛋白、触珠蛋白和维生素D浓度
J Vet Intern Med. 2017 Sep;31(5):1430-1440. doi: 10.1111/jvim.14787. Epub 2017 Aug 14.
8
A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.用于监测犬恶性淋巴瘤的犬和人血清胸苷激酶 1(TK1)的灵敏和动力学定义的放化分析法。
Vet J. 2012 Oct;194(1):40-7. doi: 10.1016/j.tvjl.2012.03.006. Epub 2012 Apr 18.
9
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.急性淋巴细胞白血病(ALL)和犬乳腺肿瘤(CMT)犬的细胞形式和血清形式胸苷激酶1(TK1)的特性:TK1作为增殖生物标志物的意义
BMC Vet Res. 2014 Oct 8;10:228. doi: 10.1186/s12917-014-0228-1.
10
AniScan Using Extracellular Cyclic AMP-Dependent Protein Kinase A as a Serum Biomarker Assay for the Diagnosis of Malignant Tumors in Dogs.AniScan 利用细胞外环腺苷酸依赖性蛋白激酶 A 作为血清生物标志物检测试剂盒,用于犬恶性肿瘤的诊断。
Sensors (Basel). 2020 Jul 22;20(15):4075. doi: 10.3390/s20154075.

本文引用的文献

1
Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors.血清胸苷激酶 1 蛋白浓度及其自身抗体的存在可作为筛查恶性肿瘤犬的生物标志物。
J Vet Intern Med. 2024 Jan-Feb;38(1):300-307. doi: 10.1111/jvim.16946. Epub 2023 Dec 13.
2
Blood biomarkers for canine cancer, from human to veterinary oncology.犬类癌症的血液生物标志物:从人类肿瘤学到兽医肿瘤学。
Vet Comp Oncol. 2022 Dec;20(4):767-777. doi: 10.1111/vco.12848. Epub 2022 Jul 20.
3
Association of periodontal disease with breed size, breed, weight, and age in pure-bred client-owned dogs in the United States.
美国纯种犬中牙周病与品种大小、品种、体重和年龄的关系。
Vet J. 2021 Sep;275:105717. doi: 10.1016/j.tvjl.2021.105717. Epub 2021 Jul 19.
4
Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies.慢性炎症与癌症发病率:流行病学研究的系统评价和荟萃分析
Crit Rev Oncol Hematol. 2021 Jan;157:103177. doi: 10.1016/j.critrevonc.2020.103177. Epub 2020 Nov 13.
5
AniScan Using Extracellular Cyclic AMP-Dependent Protein Kinase A as a Serum Biomarker Assay for the Diagnosis of Malignant Tumors in Dogs.AniScan 利用细胞外环腺苷酸依赖性蛋白激酶 A 作为血清生物标志物检测试剂盒,用于犬恶性肿瘤的诊断。
Sensors (Basel). 2020 Jul 22;20(15):4075. doi: 10.3390/s20154075.
6
Risk Factors Associated with Lifespan in Pet Dogs Evaluated in Primary Care Veterinary Hospitals.在初级保健兽医医院评估的宠物狗寿命相关风险因素。
J Am Anim Hosp Assoc. 2019 May/Jun;55(3):130-137. doi: 10.5326/JAAHA-MS-6763. Epub 2019 Mar 14.
7
Extracellular cyclic adenosine monophosphate-dependent protein kinase A autoantibody and C-reactive protein as serum biomarkers for diagnosis of cancer in dogs.细胞外环磷酸腺苷依赖性蛋白激酶A自身抗体和C反应蛋白作为犬癌症诊断的血清生物标志物。
Vet Comp Oncol. 2019 Mar;17(1):99-106. doi: 10.1111/vco.12450. Epub 2018 Nov 28.
8
Characteristics of extracellular cyclic AMP-dependent protein kinase as a biomarker of cancer in dogs.细胞外环磷酸腺苷依赖性蛋白激酶作为犬类癌症生物标志物的特征
Vet Comp Oncol. 2017 Dec;15(4):1585-1589. doi: 10.1111/vco.12304. Epub 2017 Feb 9.
9
Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.自发性患癌犬的1型胸苷激酶和C反应蛋白浓度
J Vet Intern Med. 2016 Jul;30(4):1159-66. doi: 10.1111/jvim.13954. Epub 2016 May 23.
10
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.C反应蛋白是成人实体瘤预后、肿瘤复发及治疗反应的重要生物标志物:一项系统评价
PLoS One. 2015 Dec 30;10(12):e0143080. doi: 10.1371/journal.pone.0143080. eCollection 2015.